Incidence and Prevalence of Major Central Nervous System Involvement in Systemic Lupus Erythematosus: A 3-Year Prospective Study of 370 Patients

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Kampylafka, Eleni I ^a   Alexopoulos, Haralampos ^a   Kosmidis, Michalis L ^a   Panagiotakos, Demosthenes B ^b   Vlachoyiannopoulos, Panayiotis G ^a   Dalakas, Marinos C ^a   Moutsopoulos, Haralampos M ^a   Tzioufas, Athanasios G ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b HAROKOPIO UNIVERSITY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB;

ACUTE CONFUSION; ACUTE PSYCHOSIS; ADULT; ARTICLE; ASEPTIC MENINGITIS; BRAIN INFARCTION; CENTRAL NERVOUS SYSTEM DISEASE; CHOREA; CLINICAL ASSESSMENT; DEMYELINATING DISEASE; DISEASE ACTIVITY SCORE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EPILEPTIC STATE; EUROPEAN CONSENSUS LUPUS ACTIVITY MEASUREMENT SCORE; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OPTIC NEURITIS; PREVALENCE; PROSPECTIVE STUDY; SCORING SYSTEM; SLICC DAMAGE INDEX; SPINAL CORD DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY INDEX SELENA MODIFICATION; TONIC CLONIC SEIZURE; TRANSIENT ISCHEMIC ATTACK;

ADULT; CENTRAL NERVOUS SYSTEM; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; INCIDENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PREVALENCE; PROSPECTIVE STUDIES;

EID: 84873709339     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055843     Document Type: Article

References (47)

1. D'Cruz DP, Khamashta MA, Hughes GR, (2007) Systemic lupus erythematosus. Lancet 369: 587-596.
2. Bernatsky S, Clarke A, Gladman DD, Urowitz M, Fortin PR, et al. (2006) Mortality related to cerebrovascular disease in systemic lupus erythematosus. Lupus 15: 835-839.
3. Hanly JG, Urowitz MB, Sanchez-Guerrero J, Bae SC, Gordon C, et al. (2007) Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum 56: 265-273.
4. Hanly JG, Urowitz MB, Su L, Bae SC, Gordon C, et al. (2010) Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 69: 529-535.
5. Bosnic D, Cerovec M, Anic B, Mayer M, Sentic M, et al. (2008) [Cryptococcal meningitis as a diagnostic problem in a patient with SLE-case report]. Lijec Vjesn 130: 136-140.
6. McCaffrey LM, Petelin A, Cunha BA (2011) Systemic lupus erythematosus (SLE) cerebritis versus Listeria monocytogenes meningoencephalitis in a patient with systemic lupus erythematosus on chronic corticosteroid therapy: The diagnostic importance of cerebrospinal fluid (CSF) of lactic acid levels. Heart Lung.
7. Bertsias GK, Ioannidis JP, Aringer M, Bollen E, Bombardieri S, et al. (2010) EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis 69: 2074-2082.
8. The American College of Rheumatology (1999) The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes, Appendix A. Arthritis Rheum. 42: 599-608.
9. Ainiala H, Loukkola J, Peltola J, Korpela M, Hietaharju A, (2001) The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 57: 496-500.
10. Bertsias GK, Boumpas DT, (2010) Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations. Nat Rev Rheumatol 6: 358-367.
11. Brey RL, Holliday SL, Saklad AR, Navarrete MG, Hermosillo-Romo D, et al. (2002) Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 58: 1214-1220.
12. Unterman A, Nolte JE, Boaz M, Abady M, Shoenfeld Y, et al. (2011) Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. Semin Arthritis Rheum 41: 1-11.
13. Ainiala H, Hietaharju A, Loukkola J, Peltola J, Korpela M, et al. (2001) Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum 45: 419-423.
14. Sfikakis PP, Mitsikostas DD, Manoussakis MN, Foukaneli D, Moutsopoulos HM, (1998) Headache in systemic lupus erythematosus: a controlled study. Br J Rheumatol 37: 300-303.
15. Hochberg MC, (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40: 1725.
16. Hanly JG, McCurdy G, Fougere L, Douglas JA, Thompson K, (2004) Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J Rheumatol 31: 2156-2162.
17. Kozora E, Arciniegas DB, Filley CM, West SG, Brown M, et al. (2008) Cognitive and neurologic status in patients with systemic lupus erythematosus without major neuropsychiatric syndromes. Arthritis Rheum 59: 1639-1646.
18. Petri M, Naqibuddin M, Carson KA, Sampedro M, Wallace DJ, et al. (2008) Cognitive function in a systemic lupus erythematosus inception cohort. J Rheumatol 35: 1776-1781.
19. Tektonidou MG, Varsou N, Kotoulas G, Antoniou A, Moutsopoulos HM, (2006) Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings. Arch Intern Med 166: 2278-2284.
20. Folstein MF, Folstein SE, McHugh PR, (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
21. Carlomagno S, Migliaresi S, Ambrosone L, Sannino M, Sanges G, et al. (2000) Cognitive impairment in systemic lupus erythematosus: a follow-up study. J Neurol 247: 273-279.
22. Mosca M, Bencivelli W, Vitali C, Carrai P, Neri R, et al. (2000) The validity of the ECLAM index for the retrospective evaluation of disease activity in systemic lupus erythematosus. Lupus 9: 445-450.
23. Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, et al. (2005) Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 353: 2550-2558.
24. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, et al. (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39: 363-369.
25. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, et al. (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15: 241-250.
26. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, et al. (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4: 295-306.
27. Miyachi K, Tan EM, (1979) Antibodies reacting with ribosomal ribonucleoprotein in connective tissue diseases. Arthritis Rheum 22: 87-93.
28. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR, (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202: 473-477.
29. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, et al. (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364: 2106-2112.
30. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG, (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66: 1485-1489.
31. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG, (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6: 805-815.
32. Chambers SA, Allen E, Rahman A, Isenberg D, (2009) Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years. Rheumatology (Oxford) 48: 673-675.
33. Kasitanon N, Louthrenoo W, Sukitawut W, Vichainun R, (2002) Causes of death and prognostic factors in Thai patients with systemic lupus erythematosus. Asian Pac J Allergy Immunol 20: 85-91.
34. Andrade RM, Alarcon GS, Gonzalez LA, Fernandez M, Apte M, et al. (2008) Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV). Ann Rheum Dis 67: 829-834.
35. Petri M, Genovese M, (1992) Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins Lupus Cohort. J Rheumatol 19: 1559-1565.
36. Mitsikostas DD, Sfikakis PP, Goadsby PJ, (2004) A meta-analysis for headache in systemic lupus erythematosus: the evidence and the myth. Brain 127: 1200-1209.
37. Govoni M, Bombardieri S, Bortoluzzi A, Caniatti L, Casu C, et al. (2011) Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients. Rheumatology (Oxford).
38. Mikdashi J, Handwerger B, (2004) Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort. Rheumatology (Oxford) 43: 1555-1560.
39. Karassa FB, Ioannidis JP, Touloumi G, Boki KA, Moutsopoulos HM, (2000) Risk factors for central nervous system involvement in systemic lupus erythematosus. QJM 93: 169-174.
40. Padovan M, Castellino G, Bortoluzzi A, Caniatti L, Trotta F, et al. (2010) Factors and comorbidities associated with central nervous system involvement in systemic lupus erythematosus: a retrospective cross-sectional case-control study from a single center. Rheumatol Int.
41. Costallat LT, Coimbra AM, (1994) Systemic lupus erythematosus: clinical and laboratory aspects related to age at disease onset. Clin Exp Rheumatol 12: 603-607.
42. Joseph FG, Lammie GA, Scolding NJ, (2007) CNS lupus: a study of 41 patients. Neurology 69: 644-654.
43. Valentinov Monov S, Valentinova Monova D, (2007) Neuropsychiatric lupus in patients with lupus glomerulonephritis. Med Pregl 60Suppl 2: 70-73.
44. Fujieda Y, Kataoka H, Odani T, Otomo K, Kato M, et al. (2011) Clinical features of reversible posterior leukoencephalopathy syndrome in patients with systemic lupus erythematosus. Mod Rheumatol 21: 276-281.
45. Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, et al. (2008) Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 65: 78-83.
46. Birnbaum J, Petri M, Thompson R, Izbudak I, Kerr D, (2009) Distinct subtypes of myelitis in systemic lupus erythematosus. Arthritis Rheum 60: 3378-3387.
47. Tzioufas AG, Tzortzakis NG, Panou-Pomonis E, Boki KA, Sakarellos-Daitsiotis M, et al. (2000) The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients and patients with active central nervous system disease. Ann Rheum Dis 59: 99-104.